Integrated approach toward the discovery of glyco-biomarkers of inflammation-related diseases-Reference-Cited by-同舟云学术

Integrated approach toward the discovery of glyco-biomarkers of inflammation-related diseases

Published:2012-03-01 Issue:1 Volume:1253 Page:159-169
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:

Author:

Angata Takashi,Fujinawa Reiko,Kurimoto Ayako,Nakajima Kazuki,Kato Masaki,Takamatsu Shinji,Korekane Hiroaki,Gao Cong-Xiao,Ohtsubo Kazuaki,Kitazume Shinobu,Taniguchi Naoyuki

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.2012.06469.x/fullpdf

Reference107 articles.

1. Protein biomarker discovery and validation: the long and uncertain path to clinical utility;Rifai;Nat. Biotechnol.,2006

2. The cancer biomarker problem;Sawyers;Nature,2008

3. History and recent progress in evaluation of the fucosylated alpha-fetoprotein fraction;Aoyagi;J. Gastroenterol. Hepatol.,2011

4. A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma;Taketa;Cancer Res.,1993

5. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II;Magnani;J. Biol. Chem.,1982

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Sialyl-Tn Antigen in Cancer Metastasis;Glycosignals in Cancer;2023

2. Plasma Proteomics Enable Differentiation of Lung Adenocarcinoma from Chronic Obstructive Pulmonary Disease (COPD);International Journal of Molecular Sciences;2022-09-24

3. Glycoprotein biomarkers and analysis in chronic obstructive pulmonary disease and lung cancer with special focus on serum immunoglobulin G;Clinica Chimica Acta;2020-07

4. Proteomic and Glycomic Markers to Differentiate Lung Adenocarcinoma from COPD;Current Medicinal Chemistry;2020-06-07

5. Proteomic and Glyeomie Markers to Differentiate Lung Adeno-carcinoma from COPD;CURR MED CHEM;2020